These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3599021

  • 1. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S.
    J Med Chem; 1987 Jul; 30(7):1135-44. PubMed ID: 3599021
    [Abstract] [Full Text] [Related]

  • 2. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Sanchez D, Svensson K, Hjorth S, Carlsson A, Sundell S, Kenne L.
    J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
    [Abstract] [Full Text] [Related]

  • 3. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 4. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P.
    J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
    [Abstract] [Full Text] [Related]

  • 5. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H.
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [Abstract] [Full Text] [Related]

  • 6. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE, Karlén A, Norinder U, Kenne L, Sundell S, Hacksell U.
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [Abstract] [Full Text] [Related]

  • 7. Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.
    Karlén A, Johansson AM, Kenne L, Arvidsson LE, Hacksell U.
    J Med Chem; 1986 Jun; 29(6):917-24. PubMed ID: 3712382
    [Abstract] [Full Text] [Related]

  • 8. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 9. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A.
    J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
    Johansson AM, Karlén A, Grol CJ, Sundell S, Kenne L, Hacksell U.
    Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
    [Abstract] [Full Text] [Related]

  • 11. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B.
    J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
    [Abstract] [Full Text] [Related]

  • 12. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [Abstract] [Full Text] [Related]

  • 13. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C, Liu Y, Hacksell U, Björk L, Andén NE.
    Acta Pharm Suec; 1987 Nov; 24(4):153-60. PubMed ID: 2964167
    [No Abstract] [Full Text] [Related]

  • 14. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L, Höök BB, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [Abstract] [Full Text] [Related]

  • 15. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A, Björk L, Pettersson C, Andén NE, Hacksell U.
    Chirality; 1990 Apr; 2(2):90-5. PubMed ID: 1976017
    [Abstract] [Full Text] [Related]

  • 16. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C, Vallgårda J, Nelson DL, Björk L, Yu H, Andén NE, Csöregh I, Arvidsson LE, Hacksell U.
    J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
    [Abstract] [Full Text] [Related]

  • 17. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
    Liu Y, Mellin C, Björk L, Svensson B, Csöregh I, Helander A, Kenne L, Andén NE, Hacksell U.
    J Med Chem; 1989 Oct; 32(10):2311-8. PubMed ID: 2795604
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
    Johansson AM, Fredriksson K, Hacksell U, Grol CJ, Svensson K, Carlsson A, Sundell S.
    J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
    [Abstract] [Full Text] [Related]

  • 19. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L, Mellin C, Hacksell U, Andén NE.
    Eur J Pharmacol; 1987 Nov 03; 143(1):55-63. PubMed ID: 2961582
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
    Seiler MP, Stoll AP, Closse A, Frick W, Jaton A, Vigouret JM.
    J Med Chem; 1986 Jun 03; 29(6):912-7. PubMed ID: 3712381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.